Understanding the Landscape of COVID-19 Vaccine and Treatment R&D

Understanding the Landscape of COVID-19 Vaccine and Treatment R&D

This webinar provided a high-level overview of the most promising scientific approaches underway to create vaccines, treat COVID-19 symptoms, cure serious cases, and prevent infection. Panelists discussed how the existing R&D pipeline is being leveraged to address COVID-19 and provided examples of public-private partnerships. 

Watch the recorded webinar here. (Registration required.) 

 

 

 

Moderator

Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy, Duke University

Panelists

Stefano Bertuzzi, PhD, MPH, Chief Executive Officer, American Society for Microbiology

Julie Gerberding, MD, MPH, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck

Slide Deck

Resources mentioned in the webinar:

Research!America COVID-19 Resources

Main ASM COVID-19 Resources page

ASM COVID-19 Research Registry

The Duke-Margolis Center for Health Policy Responds to the COVID-19 Crisis

PhRMA: The Latest on the Biopharmaceutical Industry's Efforts to Beat Coronavirus

Media Contacts

Robert Shalett
Director of Communications 
571-482-2737

Without research, there is no hope.
The Honorable Paul G. Rogers